Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

Bibliographic Details
Main Authors: Glueck, Charles J., Shah, Parth, Goldenberg, Naila, Prince, Marloe, Lee, Kevin, Jetty, Vybhav, Kumar, Ashwin, Goldenberg, Michael, Wang, Ping
Format: Online
Language:English
Published: BioMed Central 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788934/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788934/

Similar Items